Enhancing Diagnosis of Psoriasis and Inflammatory Skin Diseases: A Spatially Aligned Multimodal Model Integrating Clinical and Dermoscopic Images.

J Invest Dermatol

Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, Republic of China. El

Published: April 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Psoriasis is a chronic inflammatory disease with significant physical and psychological impacts. To overcome the limitations of single-modality artificial intelligence models in diagnosing inflammatory skin diseases, we propose a multimodal framework-spatial alignment multimodal contrastive learning-integrating dermoscopic and clinical photographs and trained on the developed Peking Union Medical College Hospital - Inflammatory Skin Diseases dataset, which includes 8 inflammatory skin diseases. On the Peking Union Medical College Hospital - Inflammatory Skin Diseases dataset, our model achieved classification accuracies of 0.822 for an 8-class classification task and 0.911 for a binary classification task, outperforming single-modality models and simple fusion approaches. Furthermore, on the publicly available Derm7pt dataset, the proposed model surpassed 11 state-of-the-art multimodal methods, achieving an accuracy of 0.807. When used for diagnostic assistance, the model significantly improved the diagnostic accuracy of 20 dermatologists, increasing from 0.775 to 0.890 (P < .05). Among 110 test cases, 87 (79.1%) showed improved diagnostic accuracy. The model demonstrated notable enhancements in diagnosing specific conditions, such as lichen planus, acne, rosacea, and morphea. Validation using heatmaps confirmed that the model's attention aligned with key lesion features in most cases. This study introduces a multimodal model that bridges scale discrepancies between dermoscopic and clinical photographs, offering an efficient tool for diagnosing psoriasis and other inflammatory skin diseases.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2025.03.034DOI Listing

Publication Analysis

Top Keywords

inflammatory skin
24
skin diseases
24
psoriasis inflammatory
8
multimodal model
8
dermoscopic clinical
8
clinical photographs
8
peking union
8
union medical
8
medical college
8
college hospital
8

Similar Publications

Radiotherapy, a prevalent and effective treatment for various malignancies, often causes collateral damage to normal skin and soft tissues in the irradiated area. To address this, we developed a novel approach combining SVFG-modified adipose-derived high-activity matrix cell clusters (HAMCC) with concentrated growth factors (CGF) to enhance regeneration and repair of radiation-induced skin and soft tissue injuries. Our study included cellular assays, wound healing evaluations, and histological analyses.

View Article and Find Full Text PDF

Cutibacterium acnes (C. acnes, formerly classified as Propionibacterium acnes) is a Gram-positive bacterium that contributes to the development of acne vulgaris, resulting in inflammation and pustule formation on the skin. In this study, we developed and synthesized a series of antimicrobial peptides (AMPs) that are derived from the skin secretion of Rana chensinensis.

View Article and Find Full Text PDF

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have gained prominence for their efficacy in treating type 2 diabetes and obesity. Recent evidence suggests that their pleiotropic effects-beyond glycemic control and weight loss-include anti-inflammatory, immunomodulatory, and antioxidative effects, which may beneficially support various dermatologic conditions such as psoriasis, hidradenitis suppurativa, acanthosis nigricans, and Hailey-Hailey disease. However, GLP-1 RAs are also associated with emerging cutaneous adverse drug reactions, including bullous, exanthematous and vasculitic manifestations, and other rare side effects.

View Article and Find Full Text PDF

Human YKL-40 antibody alleviates atopic dermatitis-like skin inflammation by inhibiting exosome secretion via the JAK3/STAT6 pathway.

Arch Pharm Res

September 2025

College of Pharmacy and Medical Research Center, Chungbuk National University, 194-21, Osongsaengmyeong 1-ro, Osong-eup, Cheongju-si, Chungcheongbuk-do, 28160, Republic of Korea.

Atopic dermatitis (AD) is an inflammatory skin disease that produces a variety of inflammatory cytokines and chemokines. Chitinase-3-like protein 1 (CHI3L1, YKL-40) significantly contributes to AD-associated inflammatory response and is highly expressed in patients with AD. Therefore, this study elucidated the effects and potential mechanisms of human YKL-40 antibody on AD-affected skin.

View Article and Find Full Text PDF

Design, Optimization, and Biological Evaluation of Novel Tapinarof Analogues as AHR Agonists for Topical Psoriasis Treatment.

J Med Chem

September 2025

Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

Psoriasis is a chronic inflammatory disease that affects the quality of life of patients. The aromatic hydrocarbon receptor (AHR) plays a pivotal role in maintaining the skin barrier integrity. In this study, we conducted a comprehensive analysis of the structure-activity relationship of Tapinarof analogues.

View Article and Find Full Text PDF